Dogwood Therapeutics (DWTX) Expected to Announce Quarterly Earnings on Wednesday

Dogwood Therapeutics (NASDAQ:DWTX) is projected to announce its earnings results before the market opens on Wednesday, February 26th. Analysts expect the company to announce earnings of ($1.36) per share for the quarter.

Dogwood Therapeutics Price Performance

DWTX stock opened at $5.05 on Tuesday. The company has a 50 day moving average price of $5.83. Dogwood Therapeutics has a 12 month low of $1.62 and a 12 month high of $29.28. The company has a market capitalization of $6.73 million, a price-to-earnings ratio of -0.77 and a beta of 1.92.

About Dogwood Therapeutics

Dogwood Therapeutics, Inc is a development-stage biotechnology company, which engages in developing therapeutics for pain and fatigue illness. Its product includes Halneuron. It focuses on antiviral therapies IMC-1 and IMC-2 to treat diseases associated with a viral triggered abnormal immune response such as Long-COVID and fibromyalgia.